Literature DB >> 11570307

Colorectal cancer screening. Recommendation statement from the Canadian task force on preventive health care.

.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11570307      PMCID： PMC2018577     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  17 in total

1.  The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Authors:  J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening.

Authors:  D P Berry; P Clarke; J D Hardcastle; K D Vellacott
Journal:  Br J Surg       Date:  1997-09       Impact factor: 6.939

Review 3.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.

Authors:  W Burke; G Petersen; P Lynch; J Botkin; M Daly; J Garber; M J Kahn; A McTiernan; K Offit; E Thomson; C Varricchio
Journal:  JAMA       Date:  1997-03-19       Impact factor: 56.272

4.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

5.  Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects.

Authors:  J D Hardcastle; W M Thomas; J Chamberlain; G Pye; J Sheffield; P D James; T W Balfour; S S Amar; N C Armitage; S M Moss
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

6.  Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Authors:  O Kronborg; C Fenger; J Olsen; O D Jørgensen; O Søndergaard
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

7.  Screening sigmoidoscopy and colorectal cancer mortality.

Authors:  P A Newcomb; R G Norfleet; B E Storer; T S Surawicz; P M Marcus
Journal:  J Natl Cancer Inst       Date:  1992-10-21       Impact factor: 13.506

8.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

9.  Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects.

Authors:  J Kewenter; S Björk; E Haglind; L Smith; J Svanvik; C Ahrén
Journal:  Cancer       Date:  1988-08-01       Impact factor: 6.860

10.  Multiphasic Health Checkup Evaluation: a 16-year follow-up.

Authors:  G D Friedman; M F Collen; B H Fireman
Journal:  J Chronic Dis       Date:  1986
View more
  7 in total

1.  Current awareness in Canada of clinical practice guidelines for colorectal cancer screening.

Authors:  Tracey K Asano; Daniel Toma; Hartley S Stern; Robin S McLeod
Journal:  Can J Surg       Date:  2004-04       Impact factor: 2.089

2.  User's perspectives of barriers and facilitators to implementing quality colonoscopy services in Canada: a study protocol.

Authors:  Gilles Jobin; Marie Pierre Gagnon; Bernard Candas; Catherine Dubé; Anis Ben Abdeljelil; Sonya Grenier
Journal:  Implement Sci       Date:  2010-11-02       Impact factor: 7.327

3.  Differences in colorectal cancer screening rates across income strata by levels of urbanization: results from the Canadian Community Health Survey (2013/2014).

Authors:  Jonathan Simkin; Gina Ogilvie; Brendan Hanley; Catherine Elliott
Journal:  Can J Public Health       Date:  2018-10-23

4.  Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-09-01

5.  Physician barriers to population-based, fecal occult blood test-based colorectal cancer screening programs for average-risk patients.

Authors:  S McGregor; Robert Hilsden; H Yang
Journal:  Can J Gastroenterol       Date:  2010-06       Impact factor: 3.522

6.  MiraLAX-Gatorade bowel prep versus GoLytely before screening colonoscopy: an endoscopic database study in a community hospital.

Authors:  Frederick K Shieh; Naresh Gunaratnam; Sagal O Mohamud; Philip Schoenfeld
Journal:  J Clin Gastroenterol       Date:  2012 Nov-Dec       Impact factor: 3.062

7.  Utilization of surveillance colonoscopy in community practice.

Authors:  Robert E Schoen; Paul F Pinsky; Joel L Weissfeld; Lance A Yokochi; Douglas J Reding; Richard B Hayes; Timothy Church; Susan Yurgalevich; V Paul Doria-Rose; Tom Hickey; Thomas Riley; Christine D Berg
Journal:  Gastroenterology       Date:  2009-10-08       Impact factor: 22.682
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.